HIP - is an opportunistic venture capital firm that uses a unique multi-disciplinary collaborative ecosystem model to fund innovation in healthcare. A firm with a TRUE NORTH of conducting the most detailed and complete early stage diligence in the industry - HIP has grown to over 275 investors (including 90 institutional including 18 health system strategic investors). HIP endorses an opportunity for investment ONLY after its extensive diligence and deploys capital through it's Fund and sidecar - deal by deal investment vehicle. In parallel - institutional investors in HIP deploy capital through their own structures and funds based on their independent decision but heavily weighed by the collective HIP endorsement and powerful HIP model/process.

As of late 2024 - HIP portfolio has 12 early stage healthcare technology companies. With over 75% having received multiple rounds of funding from the HIP ecosystem.

Visit our site for details to join our mission as an investor in healthcare or to seek audience for investment (fill out a short sign up form)


Biotechnology

HIP

Org chart

Teams

Offices

Similar companies